Vestjysk Bank A/S
Nasdaq Copenhagen A/S
7 January 2021
Vestjysk Bank A/S's extraordinary general meeting
On 10 December 2020, Vestjysk Bank A/S called an extraordinary general meeting to be held on 13 January 2021 at 10 a.m.
With effect from 6 January at 12.00 noon, the Danish government removed the exception to the COVID-19 ban on mass gatherings which stated that businesses were allowed to gather up to 500 seated persons at e.g. general meetings. Accordingly, the 5-person limit on public gatherings will apply to Vestjysk Bank A/S's extraordinary general meeting on 13 January 2021.
This means that, with the current COVID-19 restrictions and initiatives, it will unfortunately not be possible to allow physical access to the extraordinary general meeting of Vestjysk Bank A/S on 13 January 2021.
Instead you are invited to live-stream the general meeting on www.vestjyskbank.dk by clicking "Live-stream of extraordinary general meeting ", which will also allow you to ask questions and cast your vote. However, we still encourage you to ask questions in writing no later than on 10 January 2021. Written questions may be sent by email to investorrelations@vestjyskbank.dk .
Please see the notice calling the extraordinary general meeting with respect to registration for the meeting, the right to ask questions, procedure for casting of votes by proxy and by post which remain unchanged. We also refer to the guidelines concerning electronic extraordinary general meetings which were made available to the shareholders on Vestjysk Bank A/S's website together with the notice, and which have also been enclosed in this company announcement. Shareholders, who have already filed its registration to meet at the general meeting, will not have to register again.
7 January 2021
Vestjysk Bank A/S
Board of directors
Vestjysk Bank A/S
Torvet 4-5
DK-7620 Lemvig
Telephone +45 96 63 20 00
CVR no. 34 63 13 28
www.vestjyskbank.dk
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sampo plc15.1.2026 07:30:00 CET | Press release
Sampo plc’s share buybacks 14 January 2026
Sanofi Winthrop Industrie15.1.2026 07:00:00 CET | Press release
Press Release: Myqorzo and Redemplo approved in China
Stablepharma Ltd15.1.2026 07:00:00 CET | Press release
Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market
Santhera Pharmaceuticals Holding AG15.1.2026 07:00:00 CET | Press release
Santhera Receives Swissmedic Approval of AGAMREE® (Vamorolone) for the Treatment of Duchenne Muscular Dystrophy
Ascom Holding AG15.1.2026 07:00:00 CET | Press release
Ascom preliminary results 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
